GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Days Inventory

Scancell Holdings (LSE:SCLP) Days Inventory : 0.00 (As of Apr. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Scancell Holdings's Average Total Inventories for the six months ended in Apr. 2024 was £0.00 Mil. Scancell Holdings's Cost of Goods Sold for the six months ended in Apr. 2024 was £0.00 Mil.

The historical rank and industry rank for Scancell Holdings's Days Inventory or its related term are showing as below:

LSE:SCLP's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 188.02
* Ranked among companies with meaningful Days Inventory only.

Scancell Holdings's Days Inventory stayed the same from Apr. 2023 (0.00) to Apr. 2024 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Scancell Holdings Days Inventory Historical Data

The historical data trend for Scancell Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Days Inventory Chart

Scancell Holdings Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Days Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Scancell Holdings Semi-Annual Data
Oct14 Apr15 Oct15 Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Scancell Holdings's Days Inventory

For the Biotechnology subindustry, Scancell Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scancell Holdings's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Days Inventory falls into.



Scancell Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Scancell Holdings's Days Inventory for the fiscal year that ended in Apr. 2024 is calculated as

Days Inventory (A: Apr. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Apr. 2023 ) + Total Inventories (A: Apr. 2024 )) / count ) / Cost of Goods Sold (A: Apr. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Scancell Holdings's Days Inventory for the quarter that ended in Apr. 2024 is calculated as:

Days Inventory (Q: Apr. 2024 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Oct. 2023 ) + Total Inventories (Q: Apr. 2024 )) / count ) / Cost of Goods Sold (Q: Apr. 2024 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scancell Holdings  (LSE:SCLP) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Scancell Holdings's Inventory Turnover for the six months ended in Apr. 2024 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Scancell Holdings's Inventory to Revenue for the six months ended in Apr. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Scancell Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Scancell Holdings Business Description

Traded in Other Exchanges
Address
Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings Headlines

No Headlines